Whilst low cost playing cards can help relieve the load of significant drug costs during the short term, they do not handle the systemic problems driving up prescription selling prices in the U.S. Broader plan alterations could tackle the root causes of increasing drug costs, for example deficiency of transparency in pricing plus the job of interme